Compound Detail
CHEMBL12998
L-755507 Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CCNC[C@H](O)COc3ccc(O)cc3)cc2)cc1
Basic Information
| ChEMBL ID | CHEMBL12998 |
| Name | L-755507 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NYYJKMXNVNFOFQ-MHZLTWQESA-N |
6
Targets
15
Activities
3
Assay Types
2
PK Parameters
20
Publications
0
Known Names
Molecular Properties
584.7
MW (Da)
4.47
ALogP
7
HBA
6
HBD
149.0
PSA (Ų)
0.13
QED
2
Ro5 Violations
17
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 7 meas. best 9.37
IC50 6 meas. best 6.72
Ki 2 meas. best 6.8
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-3 adrenergic receptor CHEMBL246 | EC50 | 9.37 | 9.296 | 0.4 | 5 |
| Beta-2 adrenergic receptor CHEMBL210 | EC50 | 7.7 | 7.7 | 20.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 6.8 | 6.8 | 160.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | IC50 | 6.72 | 6.12 | 190.0 | 2 |
| Beta-1 adrenergic receptor CHEMBL213 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | EC50 | 6.48 | 6.48 | 330.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | Ki | 6.24 | 6.24 | 570.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.52 | 5.52 | 3000.0 | 1 |
| Psychosine receptor CHEMBL3714081 | IC50 | 5.29 | 5.29 | 5070.9 | 1 |
| Cruzipain CHEMBL3563 | IC50 | 4.92 | 4.92 | 12000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 1.0 | % | Canis lupus familiaris |
| F | 1.0 | % | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5724801 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5724801 | U2OS | 304 |
| - | 10.6019/CHEMBL5058577 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5058577 | U2OS | 304 |
| - | 10.6019/CHEMBL5724801 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5058577 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5058564 | U2OS | 8 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 5 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 3 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 19908840 | 10.1021/jm901070c | Cruzipain | 2 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 2 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 2 |
| 9871717 | 10.1016/s0960-894x(98)00170-x | Beta-3 adrenergic receptor | 2 |
| 9873681 | 10.1016/s0960-894x(98)00571-x | Beta-3 adrenergic receptor | 2 |
| 11311069 | 10.1021/jm000544b | Beta-1 adrenergic receptor | 2 |
| 11311069 | 10.1021/jm000544b | Beta-2 adrenergic receptor | 2 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 2 |
Data from ChEMBL 36 via Core Engine